Stay updated on Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.

Latest updates to the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page
- ChecktodayChange DetectedThe footer revision changes from v3.7.2 to v3.8.0 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA sitewide NIH banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence.” The site revision label is updated from v3.7.1 to v3.7.2.SummaryDifference1%

- Check28 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, and includes a Home link, indicating the record is temporarily inaccessible.SummaryDifference20%

- Check49 days agoChange DetectedThe page shows Revision: v3.7.0, replacing Revision: v3.6.6, indicating a version update. This update appears to be a page maintenance change rather than a study content modification.SummaryDifference0.1%

- Check63 days agoChange DetectedPage revision updated to v3.6.6, indicating a deployment/refresh of the study page. This reflects a maintenance or metadata update rather than a substantive change to study details or eligibility.SummaryDifference0.1%

Stay in the know with updates to Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.